Us Weekly Exclusive Scoops: Dolph Lundgren’s Cancer Battle and Hollywood's Biggest Revelations
By Alexander Ross
Far from the glamour of Manhattan venues, action star Dolph Lundgren presented an entirely different kind of vulnerability. The veteran actor, known worldwide for his physically imposing roles in Rocky IV and The Expendables, opened up about his multi-year confrontation with metastatic renal cell carcinoma. Lundgren revealed that in late 2020, physicians in Europe discovered tumors in his kidneys and liver, initially offering a bleak terminal prognosis of two to three years.
Refusing to accept the timeline, Lundgren sought a second opinion in Los Angeles, where medical oncologists identified a rare genomic mutation within his tumors. The shift in diagnosis allowed clinicians to bypass generic chemotherapy in favor of targeted systemic therapies and specialized immunotherapy regimens. Within months, his pulmonary and hepatic lesions shrank by more than 80%, turning an operative impossibility into an operable recovery.
His candor has reverberated through oncology communities and patient advocacy networks. Industry colleagues have rallied around the Swedish actor, who used his platform to urge patients dealing with severe diagnoses to continually demand genomic tumor profiling and independent pathology verifications before accepting palliative conclusions.
Alexander Ross has covered the video game industry for a decade, writing deep dives on game design, esports tournaments, VR developments, and gaming culture.
